Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China

Yaozu He, Weiyin Lin, Hong Li, Fei Gu, Huolin Zhong, Yun Lan, Yonghong Li, Pengle Guo, Fengyu Hu, Weiping Cai, Xiaoping Tang, Linghua LiChinese 2023 · DOI

Abstract

Long-term TDF-containing ART has high anti-HBV efficacy including relatively high overall HBsAg seroclearance in HBV/HIV co-infected patients. Lower baseline HBsAg levels, HBV genotype B, and elevated ALT levels during the first six months of ART are potential predictors of HBsAg seroclearance.
BibTeX
@inproceedings{he2023incidence,
  author = {Yaozu He and Weiyin Lin and Hong Li and Fei Gu and Huolin Zhong and Yun Lan and Yonghong Li and Pengle Guo and Fengyu Hu and Weiping Cai and Xiaoping Tang and Linghua Li},
  title = {{Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China}},
  booktitle = {Chinese},
  year = {2023},
  doi = {10.1097/cm9.0000000000002886},
}

Loading related content...

Figure